Table 1.
Mass drug administration guidelines for countries with more than 5–6 years preventive chemotherapy.
Fig 1.
Maps of the observed prevalence (left), predicted prevalence (median of posterior predictive distribution; center), and prediction uncertainty (half interval length of 95% BCI interval; right) for the three STH species. These maps were created using R’s tmap-package [29] and include administrative boundaries retrieved from gadm.org.
Fig 2.
Estimates (posterior mean and 95% BCI) of the effects of the risk factors obtained from STH species-specific, bivariate, geostatistical regression models used for variable selection purposes.
Table 2.
Parameter estimates (posterior median and 95% BCI) of the final multivariable geostatistical models for each STH species.
The parameters for the regression coefficients are given as odds ratios.
Fig 3.
Posterior probabilities of very low (top left), low (top center), moderate (top right), high (bottom left), and very high (bottom right) prevalence of any STH infection in school-age children. These maps were created using R’s tmap-package [29] and include administrative boundaries retrieved from gadm.org.
Table 3.
Population-adjusted prevalence by STH species, total number of people and number of individuals living in areas with different endemicity and annualized treatment needs by program strategy, stratified by risk group.
The reported numbers are absolute values or the median and 95%-BCI of the posterior predictive distribution.